RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Karl Thompson to Humans

This is a "connection" page, showing publications Karl Thompson has written about Humans.
Connection Strength

0.060
  1. Thompson KM, Abraham N, Jefferson KK. Staphylococcus aureus extracellular adherence protein contributes to biofilm formation in the presence of serum. FEMS Microbiol Lett. 2010 Apr; 305(2):143-7.
    View in: PubMed
    Score: 0.015
  2. Aloufi A, Aubee J, Vargas KM, Apprey V, Thompson K, Copeland R, Kanaan Y, Ricks-Santi L, Brim H, Abbas M. Vitamin D receptor polymorphisms and associated miRNAs in the development of breast cancer in African American women. Gene. 2024 Nov 15; 927:148695.
    View in: PubMed
    Score: 0.010
  3. Getachew B, Aubee JI, Schottenfeld RS, Csoka AB, Thompson KM, Tizabi Y. Ketamine interactions with gut-microbiota in rats: relevance to its antidepressant and anti-inflammatory properties. BMC Microbiol. 2018 12 22; 18(1):222.
    View in: PubMed
    Score: 0.007
  4. Eswara PJ, Brzozowski RS, Viola MG, Graham G, Spanoudis C, Trebino C, Jha J, Aubee JI, Thompson KM, Camberg JL, Ramamurthi KS. An essential Staphylococcus aureus cell division protein directly regulates FtsZ dynamics. Elife. 2018 10 02; 7.
    View in: PubMed
    Score: 0.007
  5. Tizabi Y, Getachew B, Ferguson CL, Csoka AB, Thompson KM, Gomez-Paz A, Ruda-Kucerova J, Taylor RE. Low Vs. High Alcohol: Central Benefits Vs. Detriments. Neurotox Res. 2018 Nov; 34(4):860-869.
    View in: PubMed
    Score: 0.006
  6. Wariso BA, Guerrieri GM, Thompson K, Koziol DE, Haq N, Martinez PE, Rubinow DR, Schmidt PJ. Depression during the menopause transition: impact on quality of life, social adjustment, and disability. Arch Womens Ment Health. 2017 04; 20(2):273-282.
    View in: PubMed
    Score: 0.006
  7. Chen S, Thompson KM, Francis MS. Environmental Regulation of Yersinia Pathophysiology. Front Cell Infect Microbiol. 2016; 6:25.
    View in: PubMed
    Score: 0.006
  8. Martinez PE, Rubinow DR, Nieman LK, Koziol DE, Morrow AL, Schiller CE, Cintron D, Thompson KD, Khine KK, Schmidt PJ. 5a-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder. Neuropsychopharmacology. 2016 Mar; 41(4):1093-102.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support